Free Newsletter
Pfizer's childhood vax wins WHO qualification
Free newsletter via e-mail
Tools
The WHO has granted prequalification status to Pfizer's children's pneumococcal vaccine, Prevenar 13, paving the way for United Nations agencies and governments to start ordering the product. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: